Content area
Full text
Medical technology company Smith & Nephew has entered into a definitive agreement through its subsidiaries to buy all the assets of Healthpoint Biotherapeutics for USD 782 million in cash.
Under the deal, Healthpoint in Texas, which develops and commercializes products for bioactive debridement, dermal...